Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Anti-Angiopoietin-1 Antibody (5C751)

Catalog No. TMAY-02623 Copy Product Info
🥰Excellent
Anti-Angiopoietin-1 Antibody (5C751) is a Mouse antibody targeting Angiopoietin-1. Anti-Angiopoietin-1 Antibody (5C751) can be used in ELISA.

Anti-Angiopoietin-1 Antibody (5C751)

Copy Product Info
🥰Excellent
Catalog No. TMAY-02623

Anti-Angiopoietin-1 Antibody (5C751) is a Mouse antibody targeting Angiopoietin-1. Anti-Angiopoietin-1 Antibody (5C751) can be used in ELISA.

Anti-Angiopoietin-1 Antibody
(5C751)
Pack SizePriceUSA StockGlobal StockQuantity
100 μL$1997-10 days7-10 days
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Product Introduction

Bioactivity
Description
Anti-Angiopoietin-1 Antibody (5C751) is a Mouse antibody targeting Angiopoietin-1. Anti-Angiopoietin-1 Antibody (5C751) can be used in ELISA.
Ig Type
Mouse IgG2b
Clone
5C751
Reactivity
Human
Specificity
Human Angiopoietin-1/ANGPT1
Application
Recommended Dose
ELISA: 1:1000-1:2000
Antibody Type
Monoclonal
Host SpeciesMouse
ConstructionThis antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human Angiopoietin-1 (rh Angiopoietin-1; TMPY-05435; NP_001137.2; Met1-Leu261 and Arg277-Phe498). The IgG fraction of the cell culture supernatant was purified by Protein A affinity chromatography.
PurificationProtein A
AppearanceLiquid
Formulation0.2 μm filtered solution in PBS
Research BackgroundThe angiopoietin (ANGPT)-TIE2/TEK signaling pathway is essential for blood and lymphatic vascular homeostasis. ANGPT1 is a potent TIE2 activator, whereas ANGPT2 functions as a context-dependent agonist/antagonist. In disease, ANGPT2-mediated inhibition of TIE2 in blood vessels is linked to vascular leak, inflammation, and metastasis. Primary congenital glaucoma (PCG) is a leading cause of blindness in children worldwide and is caused by developmental defects in 2 aqueous humor outflow structures, Schlemm's canal (SC) and the trabecular meshwork. We previously identified loss-of-function mutations in the angiopoietin (ANGPT) receptor TEK in families with PCG and showed that ANGPT/TEK signaling is essential for SC development. A role for the major ANGPT ligands in the development of the aqueous outflow pathway. We determined that ANGPT1 is essential for SC development, and that Angpt1-knockout mice form a severely hypomorphic canal with elevated intraocular pressure. By linking ANGPT1 with PCG, these results highlight the importance of ANGPT/TEK signaling in glaucoma pathogenesis and identify a candidate target for therapeutic development.
Related Conjugates and Formulations
Conjucates
Unconjugated
Antigen Details
Immunogen
Recombinant Protein: Human Angiopoietin-1 Protein (TMPY-05435)
Antigen Species
Human
Biology Area
Cancer Drug Targets
Chemical Properties
Stability & Storage
Stability & StorageStore at 2°C-8°C for 1 month. Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. Preservative-Free.
TransportShipping with blue ice.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator

Keywords

Related Tags: buy Anti-Angiopoietin-1 Antibody (5C751) | purchase Anti-Angiopoietin-1 Antibody (5C751) | Anti-Angiopoietin-1 Antibody (5C751) cost | order Anti-Angiopoietin-1 Antibody (5C751)